Elantas Beck

Why is Elantas Beck India Ltd falling/rising?

As of 11-Jun, Elantas Beck India Ltd's stock price is Rs 9,310.40, down 1.9%, and has underperformed the Sensex over various time frames. The stock shows declining investor interest and poor long-term growth prospects, contributing to its overall decline.

As of 11-Jun, Elantas Beck India Ltd's stock price is falling, currently at Rs 9,310.40, reflecting a decrease of Rs 180.15 or 1.9%. The stock has been on a downward trend, having lost 3.85% over the last two days and showing a significant decline of 6.96% over the past week. <BR><BR>In terms of performance relative to the benchmark Sensex, the stock has underperformed in various time frames, including a 1-month decline of 4.88% compared to the Sensex's 2.87% drop, and a 1-year decline of 13.71% against the Sensex's 10.52% decline. This suggests that the stock is not only falling but is also lagging behind the broader market.<BR><BR>Today's trading activity indicates a falling investor participation, with delivery volume dropping by 77.86% compared to the 5-day average, which may signal a lack of confidence among investors. Additionally, the stock has touched an intraday low of Rs 9,300, further indicating bearish sentiment.<BR><BR>Financially, the company has shown poor long-term growth, with operating profit growing at an annual rate of only 17.38% over the last five years. Recent quarterly results have also been disappointing, with a 15.9% decline in profit after tax compared to the previous four-quarter average, and the earnings per share reaching a low of Rs 39.19. The company's valuation appears expensive with a Price to Book Value of 7.3, and despite a return of -13.71% over the past year, profits have only increased by 7.7%, leading to a high PEG ratio of 6.5.<BR><BR>Overall, these factors contribute to the stock's decline, reflecting a combination of poor recent performance, declining investor interest, and concerns over long-term growth prospects.

Which are the latest news on Elantas Beck?

How big is Elantas Beck?

As of 10th June, Elantas Beck India Ltd has a market capitalization of 7,685.00 Cr, with recent net sales of 863.85 Cr and net profit of 146.00 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Elantas Beck India Ltd has a market capitalization of 7,685.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 863.85 Cr, while the sum of Net Profit for the same period is 146.00 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is December 2025, with Shareholder's Funds amounting to 1,008.21 Cr and Total Assets valued at 1,166.37 Cr.

Who are in the management team of Elantas Beck?

The management team of Elantas Beck includes Srikumar Ramakrishnan (Managing Director), Martin Babilas (Chairman), and several independent directors, among others. They oversee the company's operations and strategic direction.

The management team of Elantas Beck includes the following individuals:<BR><BR>1. **Suresh Talwar** - Independent Director<BR>2. **Ranjal Laxmana Shenoy** - Independent Director<BR>3. **Martin Babilas** - Chairman (Non-Executive)<BR>4. **Stefan Genten** - Alternate Director<BR>5. **Abhijit Tikekar** - Company Secretary & Compliance Officer<BR>6. **Srikumar Ramakrishnan** - Managing Director<BR>7. **Dhekne Vasant Nandkumar** - Independent Director<BR>8. **Usha Rajeev** - Independent Director<BR>9. **Ravindra Kumar** - Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Should I buy, sell or hold Elantas Beck India Ltd?

Who are the peers of the Elantas Beck?

Elantas Beck's peers include Vinati Organics, Privi Speci., Jubilant Ingrev., Alkyl Amines, Clean Science, Balaji Amines, Archean Chemical, Galaxy Surfact., and Neogen Chemicals. Elantas Beck has a good management risk rating, below average growth, and a 1-year return of -12.02%, better than Clean Science but worse than most peers.

Peers: The peers of Elantas Beck are Vinati Organics, Privi Speci., Jubilant Ingrev., Alkyl Amines, Clean Science, Balaji Amines, Archean Chemical, Galaxy Surfact., and Neogen Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at Clean Science, Alkyl Amines, and Jubilant Ingrev., while Good management risk is found at Vinati Organics, Privi Speci., Elantas Beck, Archean Chemical, and the rest. Average management risk is present at Balaji Amines, Galaxy Surfact., and Neogen Chemicals. Growth ratings show that Average growth is seen at Privi Speci., while Below Average growth is noted for Vinati Organics, Jubilant Ingrev., Alkyl Amines, Clean Science, Elantas Beck, Balaji Amines, Archean Chemical, and the rest. Capital Structure ratings indicate Excellent capital structure at Vinati Organics, Jubilant Ingrev., Alkyl Amines, Clean Science, Elantas Beck, Balaji Amines, Archean Chemical, and the rest, while Below Average capital structure is found at Privi Speci. and Neogen Chemicals.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Privi Speci. at 40.53%, while the lowest is Clean Science at -50.53%. Elantas Beck's 1-year return of -12.02% is better than Clean Science but worse than most peers. Additionally, the six-month return is negative for Clean Science, Galaxy Surfact., and Archean Chemical.

What does Elantas Beck do?

Elantas Beck India Ltd is a small-cap specialty chemicals company, primarily manufacturing products for electrical insulation and construction. As of March 2026, it reported net sales of 222 Cr and a net profit of 31 Cr, with a market cap of INR 7,685 Cr.

Overview:<BR>Elantas Beck India Ltd is a small-cap company in the specialty chemicals industry, manufacturing specialty chemicals for electrical insulation and construction sectors.<BR><BR>History:<BR>Incorporated on March 15, 1956, Elantas Beck India Ltd was formerly known as Beck India Limited. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 222 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 31 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 7,685 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 51.00 <BR>Industry P/E: 42 <BR>Dividend Yield: 0.08% <BR>Debt Equity: -0.66 <BR>Return on Equity: 14.48% <BR>Price to Book: 7.55 <BR><BR>Contact Details:<BR>Address: 147 Mumbai-Pune Road, Pimpri Pune Maharashtra : 411018 <BR>Tel: 91-20-30610600 <BR>Email: shirish.dabir@altanachemie.com <BR>Website: http://www.elantas.com/beck-india

Are Elantas Beck India Ltd latest results good or bad?

Elantas Beck India Ltd's latest results show strong revenue growth with ₹222.17 crores, a 3.24% sequential increase, but a concerning 21.01% decline in net profit to ₹31.08 crores and shrinking profit margins indicate operational challenges that may affect future profitability.

Elantas Beck India Ltd's latest results present a mixed picture. On one hand, the company achieved a quarterly revenue of ₹222.17 crores, reflecting a 3.24% sequential increase and a 7.78% growth year-on-year, which indicates strong demand for its electrical insulation products. This marks the highest quarterly sales in the company's recent history, suggesting resilience in its market.<BR><BR>However, the profit figures are concerning. The net profit of ₹31.08 crores represents a significant decline of 21.01% from the previous quarter, raising questions about the sustainability of profit margins. The operating margin also contracted to 19.51%, down from 20.90% in the prior quarter, and the PAT margin fell sharply to 13.99% from 18.29%. This margin compression, alongside a notable drop in other income, suggests that the company is facing operational challenges that could impact future profitability.<BR><BR>Overall, while the revenue growth is positive, the sharp decline in profit and margins indicates that the company is navigating some difficulties. Investors may want to monitor these trends closely as they could affect the company's performance moving forward.

How has been the historical performance of Elantas Beck?

Elantas Beck has shown consistent growth, with net sales increasing from 644.70 Cr in December 2022 to 748.51 Cr in December 2024, and profit after tax rising from 137.30 Cr to 139.56 Cr during the same period. Total assets grew to 1,015.34 Cr in December 2024, supported by an increase in shareholder's funds to 867.12 Cr.

Answer:<BR>The historical performance of Elantas Beck shows a consistent growth trend in net sales and profits over the years, with the latest figures for December 2024 indicating net sales of 748.51 Cr and a profit after tax of 139.56 Cr.<BR><BR>Breakdown:<BR>Elantas Beck has demonstrated a steady increase in net sales from 644.70 Cr in December 2022 to 748.51 Cr in December 2024. This growth is reflected in the operating profit, which rose from 131.42 Cr in December 2022 to 199.13 Cr in December 2024. The profit before tax remained relatively stable, with a slight decrease from 183.62 Cr in December 2023 to 183.45 Cr in December 2024, while profit after tax increased from 137.30 Cr to 139.56 Cr during the same period. The company's total assets also grew significantly, reaching 1,015.34 Cr in December 2024, up from 880.53 Cr in December 2023. This growth in assets is supported by an increase in shareholder's funds, which rose to 867.12 Cr in December 2024 from 731.99 Cr in December 2023. Cash flow from operating activities showed a decline from 133.00 Cr in December 2023 to 63.00 Cr in December 2024, but the overall net cash inflow improved to 136.00 Cr in December 2024, compared to a net outflow of 2.00 Cr in December 2023.

Is Elantas Beck technically bullish or bearish?

As of 14 October 2025, Elantas Beck's technical trend has shifted to bearish with moderate strength, driven by bearish MACD, Bollinger Bands, and moving averages, despite a mildly bullish signal from Dow Theory.

As of 14 October 2025, the technical trend for Elantas Beck has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST is also bearish on the weekly chart, while the Dow Theory shows a mildly bullish signal on the weekly but no trend on the monthly, indicating mixed signals. Overall, the bearish indicators outweigh the mildly bullish signal from Dow Theory.

Is Elantas Beck overvalued or undervalued?

As of April 7, 2020, Elantas Beck is considered very expensive and overvalued with a PE ratio of 59.66, significantly higher than peers like Godrej Industries and Deepak Nitrite, despite a strong 3-year return of 165.28% and a year-to-date decline of 19.45%.

As of 7 April 2020, Elantas Beck's valuation grade has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued. Key ratios include a PE ratio of 59.66, an EV to EBITDA of 51.32, and a Price to Book Value of 9.33, all of which are considerably high compared to industry standards.<BR><BR>In comparison with peers, Elantas Beck's PE ratio is notably higher than Godrej Industries, which has a PE of 46.63 and is rated as attractive, and Deepak Nitrite, which has a PE of 37.97 and is also rated very expensive. The high valuation ratios suggest that Elantas Beck is trading at a premium compared to its peers, reinforcing the conclusion of overvaluation. Despite a strong 3-year return of 165.28%, the recent performance shows a year-to-date decline of 19.45%, further highlighting the disconnect between valuation and market performance.

Who are the top shareholders of the Elantas Beck?

The top shareholders of Elantas Beck are Elantas GmbH with 75.0%, followed by Nippon Life India Trustee Ltd at 7.75%, mutual funds with 11.69%, foreign institutional investors at 0.51%, and individual investors holding 9.31%.

The top shareholders of Elantas Beck include Elantas GmbH, which holds a significant 75.0% of the shares, making it the largest promoter. The highest public shareholder is Nippon Life India Trustee Ltd, representing the Nippon India Small Cap Fund, with a holding of 7.75%. Additionally, mutual funds collectively hold 11.69% through three schemes, while foreign institutional investors (FIIs) hold 0.51% across four entities. Individual investors account for 9.31% of the shares.

When is the next results date for Elantas Beck?

No Upcoming Board Meetings

Has Elantas Beck declared dividend?

Elantas Beck India Ltd has declared a 75% dividend, amounting to ₹7.5 per share, with an ex-date of April 23, 2025. While the company has shown significant long-term growth, recent short-term returns have been negative.

Elantas Beck India Ltd has declared a 75% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 75%<BR>- Amount per share: 7.5<BR>- Ex-date: April 23, 2025<BR><BR>Dividend Yield: 0.08%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -22.26%, the dividend return was 0.06%, resulting in a total return of -22.2%.<BR><BR>Over the past year, the price return was -8.88%, the dividend return was 0.07%, leading to a total return of -8.81%.<BR><BR>In the 2-year period, the price return was 62.03%, the dividend return was 0.20%, culminating in a total return of 62.23%.<BR><BR>For the 3-year period, the price return was 158.6%, the dividend return was 0.49%, resulting in a total return of 159.09%.<BR><BR>In the last 4 years, the price return was 183.26%, the dividend return was 0.60%, leading to a total return of 183.86%.<BR><BR>Over the past 5 years, the price return was 335.14%, the dividend return was 1.44%, resulting in a total return of 336.58%.<BR><BR>Overall, Elantas Beck has declared a substantial dividend, which, while contributing to total returns, has seen varied performance across different periods, with significant growth in the longer term despite recent declines in shorter periods.